Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia

Published:2004-02 Issue:9408 Volume:363 Page:535-536
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ferrando Adolfo A,Neuberg Donna S,Dodge Richard K,Paietta Elisabeth,Larson Richard A,Wiernik Peter H,Rowe Jacob M,Caligiuri Michael A,Bloomfield Clara D,Look A Thomas

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia;Ferrando;Cancer Cell,2002

2. A class of K-sample tests for comparing the cumulative incidence of competing risk;Gray;Anal Stat,1998

3. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia;Ferrando;Semin Hematol,2000

4. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG);Kees;Leukemia,2003

5. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia;Fiere;J Clin Oncol,1993

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

2. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

3. Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL;HemaSphere;2023-03-17

4. Leukemias, Lymphomas, and Plasma Cell Disorders;Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics;2023

5. Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis;Cancer Gene Therapy;2022-02-10